Benjamin L Blend, MD in Bozeman, MT - Pathology

Benjamin L Blend, MD is a Pathology - Anatomic Pathology & Clinical Pathology physician based in Bozeman, Montana. Benjamin L Blend is licensed to practice in Montana (license number 9620) and his current practice location is 931 Highland Blvd, Suite 3220, Bozeman, Montana. He can be reached at his office (for appointments etc.) via phone at (406) 587-1261.

NPI number for Benjamin L Blend is 1588657456 and his current mailing address is 931 Highland Blvd, Suite 3220, Bozeman, Montana. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1588657456.

Contact Information

	Benjamin L Blend, MD
	931 Highland Blvd, Suite 3220, Bozeman, MT 59715-6911
	(406) 587-1261
	(406) 587-3928

Physician's Profile

Full Name	Benjamin L Blend
Gender	Male
Speciality	Pathology - Anatomic Pathology & Clinical Pathology
Location	931 Highland Blvd, Bozeman, Montana
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1588657456
Provider Enumeration Date: 08/25/2005
Last Update Date: 04/09/2008

Medical Identifiers

Medical identifiers for Benjamin L Blend such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1588657456	NPI	-	NPPES
0059917	Medicaid	MT
P00009090	Other		RAILROAD MEDICARE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207ZP0102X	Pathology - Anatomic Pathology & Clinical Pathology	9620 (Montana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Benjamin L Blend is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Benjamin L Blend, MD 931 Highland Blvd, Suite 3220, Bozeman, MT 59715-6911 Ph: (406) 587-1261	Benjamin L Blend, MD 931 Highland Blvd, Suite 3220, Bozeman, MT 59715-6911 Ph: (406) 587-1261

News Archive

Metformin can activate neural stem cells to encourage brain repair

The discovery is an important step toward therapies that aim to repair the brain not by introducing new stem cells but rather by spurring those that are already present into action, says the study's lead author Freda Miller of the University of Toronto-affiliated Hospital for Sick Children. The fact that it's a drug that is so widely used and so safe makes the news all that much better.

Cannabinoid compounds may reduce viability of colon cancer cells

Medical marijuana has gained attention in recent years for its potential to relieve pain and short-term anxiety and depression. Now, Penn State College of Medicine researchers say some cannabinoid compounds may actually inhibit the growth of colon cancer cells in the lab.

Osteoarthritis susceptibility: eight potential genes discovered

The largest genome-wide association study (GWAS) of osteoarthritis to date, published Online First in The Lancet, has uncovered eight new genetic variants or loci that appear to increase susceptibility to the most common form of arthritis, which affects about 40% of the world population older than 70 years. These findings bring the total number of osteoarthritis susceptibility genes isolated in European populations to 11.

AAOS releases clinical practice guideline to treat rotator cuff tears

The American Academy of Orthopaedic Surgeons Board of Directors approved and released a clinical practice guideline for treating rotator cuff tears.

Abbott and Enanta's ABT-450/r Phase 2 study results against HCV presented at EASL meeting

Abbott and Enanta Pharmaceuticals today announced 12-week results from a Phase 2 study of ABT-450/r, an investigational, oral protease inhibitor being developed for the treatment of hepatitis C infection.

Benjamin L Blend, MD - Pathology in Bozeman, MT